aod9604 clinical trial weight loss results kg or percent The effect of a single daily ip dose of saline, AOD9604, hGH on body AOD‑9604 Peptide for Fat Loss:

Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy

Topical delivery puts far less copper into the body than oral or intravenous routes, and the skin barrier limits absorption, so the systemic exposure from a copper-peptide serum is plausibly low

Great products

The benefit of AHK-Cu is that there's more research behind it for hair growth, as the AHK peptide combination has a higher affinity to hair follicles